Publications

Huffman BM, Diossy M, Yurgelun MB, et al. A Phase II Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2. Clinical cancer research : an official journal of the American Association for Cancer Research. 2026;32(9):1666-1677. doi:10.1158/1078-0432.CCR-24-3766
PMCID
PMC13002239